Last reviewed:
Home HIV tests can be useful when used correctly and at the right time. FDA reports about 92% sensitivity for OraQuick in its home-use studies: roughly one false negative per 12 tests in people who had HIV, not per 12 tests overall. OraQuick and the fingerstick INSTI self-test detect antibodies. A reactive result needs medical follow-up; a negative result soon after exposure cannot rule out HIV.[1][2][9]
What FDA actually says about the numbers
FDA's own information page on the OraQuick In-Home HIV Test states that clinical studies have shown expected performance of approximately 92% for test sensitivity — the percentage of results that will be positive when HIV is present — and that this means one false negative result would be expected out of every 12 test results in people living with HIV.[1]
The 92% estimate describes this particular product in its home-use studies; it is not a universal accuracy figure for every self-test. FDA also reports 99.98% specificity for OraQuick among people without HIV. Neither percentage tells you the chance that your own result is right without considering timing and clinical context. Antibody tests using venous blood generally detect infection sooner than fingerstick or oral-fluid antibody tests.[1][2]
Two rapid self-tests are currently FDA-approved in the United States: OraQuick uses oral fluid, and INSTI uses fingerstick blood. INSTI received FDA approval on October 9, 2025; its label is for people aged 18 or older.[9][3][4]
Three different things get called a "home test"
A rapid self-test is completed in a private setting, without mailing a sample. The approved U.S. self-tests detect antibodies. Follow the specific kit instructions and reading time; for OraQuick, FDA specifies reading the result at 20–40 minutes. Antibody tests usually detect infection 23–90 days after exposure.[1][5][2]
A mail-in collection kit is different: you collect a sample and send it elsewhere. Do not assume its performance or detection window matches a laboratory test using blood drawn from a vein. FDA warned in October 2024 about unapproved HIV blood self-collection kits, including dried-blood-spot kits, and the effect of collection and shipping on reliable results.[10][2]
A clinical nucleic acid test (NAT) looks for HIV itself and can usually detect infection 10–33 days after exposure. CDC describes it using venous blood collected by a provider and sent to a laboratory. That interval is not an assurance about an unvalidated mail-in kit. Ask a provider which test and specimen are appropriate.[10][2]
For a recent exposure, choose a testing service with a clinician who can assess timing and whether a lab antigen/antibody test or NAT is needed. If the exposure was within 72 hours, seek PEP assessment immediately; do not wait for a self-test or mailed result.[11]
Reading your result correctly
Always interpret a self-test result according to the manufacturer's instructions, and use the help phone number included with the kit if anything is unclear. If the test reads invalid, it did not work — you will need another self-test or testing at a provider or testing center.[5]
A positive self-test is preliminary. HIV.gov states that a positive result from an HIV self-test requires a second test from a health care provider to be sure of your status.[3] CDC says the same for any positive antibody test.[2]
A negative self-test is only as good as its timing. CDC's instruction after a potential exposure is to retest after the window period for the test you took.[2]
No matter the result, you are not alone in it. CDC points people to prevention service locators for support after a self-test, and a preliminary positive is a reason to make a call, not a reason to spiral.[5]
Florida angle: the state will mail you a kit for free
Florida residents can request a free OraQuick kit through KnowYourHIVStatus.com. Follow the kit instructions, and contact the program about availability. The Florida Department of Health also lists more than 1,600 publicly funded and registered testing sites; the services and tests offered vary by location. For a recent exposure, ask a clinic about the appropriate blood test rather than waiting for an oral-fluid self-test to become informative.[6][7][8]
Related questions
Can a home HIV test give a false positive?
Is the fingerstick self-test better than the oral one?
OraQuick and INSTI are both antibody tests. The fact that one uses fingerstick blood does not establish a shorter personal window period. CDC lists a usual antibody-test window of 23–90 days; its 18–45-day interval specifically concerns a laboratory antigen/antibody test using blood from a vein. Ask about clinical testing if the exposure was recent.[2][9]
How soon after a possible exposure can I use a home test?
Antibody tests usually detect HIV 23–90 days after exposure. A negative result before the relevant window has ended cannot rule out that infection. Tell the testing provider about PrEP or PEP, which can change detection and follow-up. For an exposure within 72 hours, seek PEP assessment now rather than waiting to test later.[2][11]
Do I need to report a home test result to anyone?
Take a reactive home result to a provider or health department for confirmation and help accessing care. HIV testing and reporting laws vary by state. Ask the service how your information is protected and which results it must report; a home screening result is not itself a confirmed diagnosis.[2][4]
Related from RiseUpToHIV
References & Sources
- FDA — OraQuick In-Home HIV Test: product-specific study sensitivity and specificity, correct denominators, reading time and need for follow-up. Source. ↩ ↩ ↩ ↩ ↩
- CDC — Getting Tested for HIV. Publishes window periods by test type, notes venous blood detects HIV sooner than fingerstick or oral fluid, requires confirmation of positive antibody tests, and advises retesting after the window period. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- HIV.gov — HIV Testing Overview. States only two rapid self-tests are FDA-approved (one oral fluid, one fingerstick) and that a positive self-test requires a second provider-administered test. ↩ ↩
- CDC HIV Nexus — Clinical Testing Guidance for HIV. States there are two rapid self-tests currently available in the United States and names OraQuick and INSTI. ↩ ↩
- CDC — HIV self-testing: interpretation, invalid results and connection to services; use each product’s instructions. Source. ↩↩↩
- Florida Department of Health — HIV Prevention: testing locations and the state home-test referral. Source. ↩
- Florida Department of Health — Free at-home HIV testing for Florida residents; OraQuick request program. Source. ↩
- Florida Department of Health — HIV Prevention. States Florida has over 1,600 publicly funded and registered HIV testing sites. ↩
- FDA — INSTI HIV Self Test; approval October 9, 2025 and fingerstick-only indication for users 18 or older. Source. Checked September 21, 2026. ↩ ↩ ↩
- FDA (October 29, 2024) — Warning about unapproved HIV blood self-collection kits; this dated notice predates INSTI approval. Source. Checked September 21, 2026. ↩ ↩
- CDC (2025) — Nonoccupational PEP guidance, urgent initiation and testing when antiretrovirals can affect detection. Source. Checked September 21, 2026. ↩ ↩ ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.